# SafeHeal

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/safeheal

- Industry: Medical Devices & Equipment
- Headquarters: Paris, France
- Website: www.safeheal.com
- Total disclosed funding: $84M
- Latest round: Series C (Sep 1, 2025)
- Investors on record: 7

## About

Based in France, SafeHeal SAS develops innovative medical devices aimed at improving recovery outcomes for patients following colorectal surgery.SafeHeal SAS is focused on creating medical devices that enhance surgical recovery for colorectal surgeries. Founded in 2015 and headquartered in Paris, France, the company has completed three funding deals. In September 2025, SafeHeal SAS raised EUR 10 million in series C funding led by new investor Asabys Partners, with participation from other new investors Solar Eclipse and Polis. Returning investors Sofinnova Partners, Gideon Strategic Partners, and M&L Healthcare also participated in the round. The round was part of a larger EUR 45 million series C funding. SafeHeal specializes in innovative medical devices designed to improve recovery outcomes for patients undergoing colorectal surgery. Their core product, Colovac, aims to protect colorectal anastomoses by minimizing exposure to fecal matter, thus reducing the likelihood of complications such as anastomotic leaks. This device offers an alternative to traditional diverting ostomies, primarily targeting hospitals and surgical clinics, especially among colorectal surgeons in Europe and the United States.SafeHeal generates revenue through direct sales of its Colovac device to medical institutions and healthcare providers engaged in colorectal procedures. The revenue model is primarily B2B, with a focus on hospitals conducting clinical trials. The Colovac device is classified as investigational, indicating ongoing clinical studies to validate its efficacy. SafeHeal SAS will use the September 2025 funding to improve investment strategies by leveraging proprietary data from its portfolio companies.

## Funding rounds

- Series C, Sep 1, 2025, $12M — Sofinnova Partners, Asabys Partners, M&L Healthcare, Gideon Strategic Partners, Solar Eclipse, Polis
- Series C, Apr 30, 2025, $40M — Sofinnova Partners, M&L Healthcare, Gideon Strategic Partners
- Series B, Jan 13, 2022, $25M — Sofinnova Partners, Genesis Medtech
- Series A, Mar 8, 2018, $7.4M — Sofinnova Partners

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A, Series B, Series C
- Genesis Medtech — Series B
- M&L Healthcare — Series C
- Gideon Strategic Partners (https://capitalatlas.ai/funds/gideon-strategic-partners) — Series C
- Asabys Partners (https://capitalatlas.ai/funds/asabys-partners) — Series C
- Solar Eclipse — Series C
- Polis — Series C